Balaxi Pharmaceuticals Ltd.

Sector Commercial Services & Supplies Industry Commodity Trading & Distribution

74.73

-5.46 (-6.81%)

Sector Commercial Services & Supplies Industry Commodity Trading & Distribution

NSE BSE

Sector Commercial Services & Supplies
Industry Commodity Trading & Distribution

74.73

-5.46 (-6.81%)
15:53 Dec 20

Quality

50/100
Medium Financial Strength

Valuation

68/100
Affordable Valuation

Technical

27/100
Technically Bearish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	231.33	279.39	336.43	241.29	263.61
Operating Expenses +	188.92	229.19	279.9	194.56	215.82
Raw Material	172.15	195.6	202.42	128.68	141.55
Increase Decrease in Cost	0	0	0	0	0
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	8.47	12.47	28.95	28.04	30.46
Miscellaneous Expenses	8.3	21.12	48.53	37.84	43.81
Operating Profit	42.41	50.2	56.53	46.73	47.79
Other Income	2.23	4.97	2.64	-2.65	-7.88
Depreciation	0.3	0.51	1.75	2.1	2.1
Interest	0.01	0.14	0.5	1.68	1.83
Profit before tax and exceptio..	44.33	54.52	56.92	40.31	35.98
Exceptional Items	0	0	0	-38.29	2.73
PBT	44.33	54.52	56.92	2.02	33.25
Provision for Taxation	6.19	6.86	10.96	4.4	3.1
Net Profit	38.14	47.66	45.96	-2.39	35.59
NET Profit after MI	38.14	47.66	45.96	-2.39	35.59
EPS	38.14	47.66	45.4	-2.32	25.71
Operating Profit Margin (%)	18.33	17.97	16.8	19.37	18.13
Net Profit Margin (%)	16.49	17.06	13.66	-0.99	13.5

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	66.00	66.00	66.90	71.20	71.20
FII	16.50	16.90	17.20	18.60	18.60
MF	0.00	0.00	0.00	0.00	0.00
Public	17.50	17.10	15.90	10.20	10.20
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00